TY  - ADVS
AU  - Paul,Thomas A.
TI  - Cancer-specific epigenetic alterations as investigated from a pharmaceutical perspective
T2  - The biomedical & life sciences collection,
PY  - 2021///
CY  - London
PB  - Henry Stewart Talks
KW  - Antineoplastic agents
KW  - Development
KW  - Cancer
KW  - Genetic aspects
KW  - Epigenesis
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Chromatin Assembly and Disassembly
KW  - genetics
KW  - Epigenesis, Genetic
KW  - Histone Deacetylase Inhibitors
KW  - Neoplasms
KW  - drug therapy
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Chromatin dysregulation in cancer -- Features of epigenetic information in cells -- Mutated chromatin regulatory factors as tumor drivers -- Therapeutic rationale for the use of epigenetic drugs in oncology -- First generation epigenetic drugs: DNMT and HDAC inhibitors -- Novel therapeutic discoveries in oncology -- Biomarkers for patient selection; Access restricted to subscribers
UR  - https://hstalks.com/bs/4491/
ER  -